Compile Data Set for Download or QSAR
Report error Found 45 of ic50 data for polymerid = 421,422,6801
TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144297(US8969336, 388)
Affinity DataIC50: 0.170nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144299(US8969336, 392)
Affinity DataIC50: 0.210nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144298(US8969336, 391)
Affinity DataIC50: 0.220nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144295(US8969336, 383)
Affinity DataIC50: 0.230nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144293(US8969336, 377)
Affinity DataIC50: 0.240nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144296(US8969336, 387)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144294(US8969336, 378)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144303(US8969336, 459)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144290(US8969336, 355)
Affinity DataIC50: 0.330nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144301(US8969336, 406)
Affinity DataIC50: 0.340nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144285(US8969336, 340)
Affinity DataIC50: 0.370nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144302(US8969336, 426)
Affinity DataIC50: 0.490nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144292(US8969336, 370)
Affinity DataIC50: 0.650nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144289(US8969336, 354)
Affinity DataIC50: 0.770nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144304(US8969336, 466)
Affinity DataIC50: 0.930nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144300(US8969336, 399)
Affinity DataIC50: 0.940nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144281(US8969336, 110)
Affinity DataIC50: 0.990nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144310(US8969336, 534)
Affinity DataIC50: 1nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50: 1.40nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human AL...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144318(US8969336, 580 | US8969336, 553)
Affinity DataIC50: 1.40nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50: 1.5nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human AL...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144315(US8969336, 577 | US8969336, 547 | Gilteritinib | U...)
Affinity DataIC50: 1.5nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144309(US8969336, 574 | US8969336, 512)
Affinity DataIC50: 1.5nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144288(US8969336, 347)
Affinity DataIC50: 1.70nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144312(US8969336, 544)
Affinity DataIC50: 1.90nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144287(US8969336, 343)
Affinity DataIC50: 2.10nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144316(US8969336, 578 | US8969336, 549)
Affinity DataIC50: 2.10nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144320(US8969336, 582 | US8969336, 558)
Affinity DataIC50: 2.20nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144311(US8969336, 538)
Affinity DataIC50: 2.30nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144307(US8969336, 494 | US8969336, 493)
Affinity DataIC50: 2.60nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM50306682((R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1...)
Affinity DataIC50: 2.70nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human AL...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144306(US8969336, 491)
Affinity DataIC50: 2.80nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144286(US8969336, 341)
Affinity DataIC50: 2.80nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM50306682((R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1...)
Affinity DataIC50: 2.90nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human AL...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144305(US8969336, 490)
Affinity DataIC50: 3.10nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144307(US8969336, 494 | US8969336, 493)
Affinity DataIC50: 4.10nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144319(US8969336, 581 | US8969336, 554)
Affinity DataIC50: 4.5nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144283(US8969336, 325)
Affinity DataIC50: 5.30nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144314(US8969336, 576 | US8969336, 546)
Affinity DataIC50: 7.80nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144282(US8969336, 284)
Affinity DataIC50: 8.90nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144313(US8969336, 545)
Affinity DataIC50: 11nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144317(US8969336, 579 | US8969336, 550)
Affinity DataIC50: 11nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144291(US8969336, 357)
Affinity DataIC50: 17nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144280(US8969336, 86)
Affinity DataIC50: 17nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144284(US8969336, 328)
Affinity DataIC50: 76nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent